SCHEMBL9532945

SCHEMBL9532945

CCCc1c(C)n(CC)c(=O)n1Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.57
AGTR1 P30556 2/20 0.56
AGTR2 P50052 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532126 0.94 PPARG (0.58) PPARGAGTR1AGTR2
SCHEMBL9554381 0.94 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL9532889 0.93 AGTR1 (0.57) PPARGAGTR1AGTR2
SCHEMBL9036172 0.91 AGTR1 (0.63) PPARGAGTR1AGTR2
SCHEMBL9533795 0.91 PPARG (0.57) PPARGAGTR1AGTR2
SCHEMBL9536354 0.90 PPARG (0.53) PPARGAGTR1AGTR2
SCHEMBL9530481 0.90 AGTR1 (0.60) PPARGAGTR1AGTR2
SCHEMBL9536006 0.90 AGTR1 (0.50) PPARGAGTR1AGTR2
SCHEMBL9555337 0.89 PPARG (0.57) PPARG
SCHEMBL9555008 0.89 PPARG (0.57) PPARGAGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0385038-B1 ORTHO-SUBSTITUTED PHENYL AMIDINE AND PHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM The Boots Company PLC (GB) 1993-06-02 EP claimed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed